BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10654274)

  • 1. Management of peritoneal-surface malignancy: the surgeon's role.
    Sugarbaker PH
    Langenbecks Arch Surg; 1999 Dec; 384(6):576-87. PubMed ID: 10654274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of a personal experience in the management of carcinomatosis and sarcomatosis.
    Sugarbaker PH
    Jpn J Clin Oncol; 2001 Dec; 31(12):573-83. PubMed ID: 11902487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for the prevention and treatment of peritoneal carcinomatosis from gastrointestinal cancer.
    Sugarbaker PH
    Cancer Invest; 2005; 23(2):155-72. PubMed ID: 15813509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal surface oncology: review of a personal experience with colorectal and appendiceal malignancy.
    Sugarbaker PH
    Tech Coloproctol; 2005 Jul; 9(2):95-103. PubMed ID: 16007367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.
    Sugarbaker PH; Chang D
    Ann Surg Oncol; 1999 Dec; 6(8):727-31. PubMed ID: 10622499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.
    Pestieau SR; Sugarbaker PH
    Dis Colon Rectum; 2000 Oct; 43(10):1341-6; discussion 1347-8. PubMed ID: 11052509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma.
    Begossi G; Gonzalez-Moreno S; Ortega-Perez G; Fon LJ; Sugarbaker PH
    Eur J Surg Oncol; 2002 Feb; 28(1):80-7. PubMed ID: 11869020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreduction and intraperitoneal chemotherapy for the management of non-gynecological peritoneal surface malignancy.
    Yan TD; Esquivel J; Carmignani P; Sugarbaker PH
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):109-17. PubMed ID: 16767916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
    Sugarbaker PH
    Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure.
    Sugarbaker PH; Yonemura Y
    Oncology; 2000 Feb; 58(2):96-107. PubMed ID: 10705236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of peritoneal carcinomatosis secondary to metastatic cancer of unknown primary in men.
    Mugerwa S; Lekharaju V; Kiire CF
    Eur J Cancer Care (Engl); 2009 Jan; 18(1):22-7. PubMed ID: 19016832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer.
    Sugarbaker PH
    World J Surg; 1995; 19(2):235-40. PubMed ID: 7754629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.
    Nesher E; Greenberg R; Avital S; Skornick Y; Schneebaum S
    Isr Med Assoc J; 2007 Nov; 9(11):787-90. PubMed ID: 18085034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment results of peritoneal dissemination from gastric cancer by neoadjuvant intraperitoneal-systemic chemotherapy].
    Yonemura Y; Kawamura T; Bando E; Takahashi S; Sawa T; Yoshimitsu Y; Obata T; Endo Y; Sasaki T; Sugarbaker PH
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1723-6. PubMed ID: 15553695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful management of microscopic residual disease in large bowel cancer.
    Sugarbaker PH
    Cancer Chemother Pharmacol; 1999; 43 Suppl():S15-25. PubMed ID: 10357554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritonectomy procedures.
    Sugarbaker PH
    Ann Surg; 1995 Jan; 221(1):29-42. PubMed ID: 7826158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features.
    Portilla AG; Sugarbaker PH; Chang D
    World J Surg; 1999 Jan; 23(1):23-9. PubMed ID: 9841759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion for peritoneal carcinomatosis caused by recurrent inflammatory myofibroblastic sarcoma: a case report and review of the literature].
    Mátrai Z; Péley G; Kovács T; Rényi VF; Szívós E; Szabó E; Vereczkey I; Török K; Köves I
    Orv Hetil; 2006 Jan; 147(4):147-58. PubMed ID: 16515023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
    Koppe MJ; Boerman OC; Oyen WJ; Bleichrodt RP
    Ann Surg; 2006 Feb; 243(2):212-22. PubMed ID: 16432354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palliation with a glimmer of hope: management of resectable gastric cancer with peritoneal carcinomatosis.
    Sugarbaker PH; Yonemura Y
    Hepatogastroenterology; 2001; 48(41):1238-47. PubMed ID: 11677938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.